Abstract
For more than a century, no FDA-approved alternative to SCIT immunotherapy has been presented. We explored the use of a novel protocol with a ramp-up phase of sublingual administration followed by vestibular maintenance immunotherapy. Nocturnal administration offers physiological advantages due to the circadian cycle changes of the immune system. The dendritic-rich vestibular space is a desirable location for immunotherapy delivery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
